Urine albumin concentration and albumin-to-creatinine ratio at 11 +0 to 13+6 weeks in the prediction of pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 115, Issue 7, 2008, Pages 866-873

  Poon, L C Y ^a   Kametas, N ^a   Bonino, S ^a   Vercellotti, E ^a   Nicolaides, K H ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Albumin to creatinine ratio; First trimester; Pre eclampsia; Screening; Urine albumin concentration

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE URINE LEVEL; ETHNICITY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PARITY; PREECLAMPSIA; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SMOKING;

ADOLESCENT; ADULT; ALBUMINURIA; BIOLOGICAL MARKERS; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES;

EID: 43749084102     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01650.x     Document Type: Article

References (40)

1. WHO. Make Every Mother and Child Count. World Health Report, 2005. Geneva, Switzerland : World Health Organization, 2005.
2. Lewis G, editor. Why Mothers Die 2000-2002: The Sixth Report of Confidential Enquiries into Maternal Deaths in the United Kingdom. London : RCOG Press, 2004.
3. ACOG Committee on Practice Bulletins - Obstetrics. ACOG practice bulletin: diagnosis and management of pre-eclampsia and eclampsia: number 33, January 2002. Obstet Gynecol 2002 99 : 159 67.
4. Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali MM, Zavaleta N, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol 2006 194 : 639 49.
5. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS ACTS Study Group. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med 2006 354 : 1796 806.
6. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006 367 : 1145 54.
7. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA on behalf of the PARIS Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007 369 : 1791 8.
8. Moutquin JM, Rainville C, Giroux L, Raynauld P, Amyot G, Bilodeau R, et al. A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol 1985 151 : 191 6.
9. Irgens-Møller L, Hemmingsen L, Holm J. Diagnostic value of microalbuminuria in pre-eclampsia. Clin Chim Acta 1986 157 : 295 8.
10. Rodriguez MH, Masaki DI, Mestman J, Kumar D, Rude R. Calcium/creatinine ratio and microalbuminuria in the prediction of preeclampsia. Am J Obstet Gynecol 1988 159 : 1252 5.
11. Konstantin-Hansen KF, Hesseldahl H, Pedersen SM. Microalbuminuria as a predictor of preeclampsia. Acta Obstet Gynecol Scand 1992 71 : 343 6.
12. Baker PN, Hackett GA. The use of urinary albumin-creatinine ratios and calcium-creatinine ratios as screening tests for pregnancy-induced hypertension. Obstet Gynecol 1994 83 : 745 9.
13. Das V, Bhargava T, Kumar Das S, Pandey S. Microalbuminuria: a predictor of pregnancy-induced hypertension. Br J Obstet Gynaecol 1996 103 : 928 30.
14. Salako BL, Olayemi O, Odukogbe A-TA, Adedapo KS, Aimakhu CO, Alu FE, et al. Microalbuminuria in pregnancy as a predictor of preeclampsia and eclampsia. West Afr J Med 2003 22 : 295 300.
15. Shaarawy M, Salem ME. The clinical value of microtransferrinuria and microalbuminuria in the prediction of pre-eclampsia. Clin Chem Lab Med 2001 39 : 29 34.
16. Bar J, Hod M, Erman A, Friedman S, Gelerenter I, Kaplan B, et al. Microalbuminuria as an early predictor of hypertensive complications in pregnant women at high risk. Am J Kidney Dis 1996 28 : 220 5.
17. Lopez-Espinoza I, Dhar H, Humphreys S, Redman CWG. Urinary albumin excretion in pregnancy. Br J Obstet Gynaecol 1986 93 : 176 81.
18. ® 2000 microalbumin:creatinine ratio urinanalyzer for its use in pregnancy and preeclampsia. Hypertens Pregnancy 2003 22 : 77 92.
19. Douma CE, Van de post JAM, Van Acker BAC, Boer K, Koopman MG. Circadian variation of albumin excretion in pregnancy. Br J Obstet Gynaecol 1995 102 : 107 10.
20. Snidjers RMJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 1998 351 : 343 6.
21. Carroll MF, Temte JL. Proteinuria in adults: a diagnostic approach. Am Fam Physician 2000 62 : 1333 42.
22. Ruggenenti P, Remuzzi G. Time to abandon microalbuminuria? Kidney Int 2006 70 : 1214 22.
23. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988 158 : 892 8.
24. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH Fetal Medicine Foundation Second Trimester Screening Group. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001 18 : 441 9.
25. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? BJOG 2004 111 : 298 302.
26. Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD. Impact of preeclampsia and gestational hypertension on birthweight by gestational age. Am J Epidemiol 2002 115 : 203 9.
27. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M, et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002 39 : 445 59.
28. Bryson CL, Ross HJ, Boyko EJ, Young B. Racial and ethnic variations in albuminuria in the US third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. Am J Kidney Dis 2006 48 : 720 6.
29. Wetzels JFM, Kiemeney LALM, Swinkels DW, Willems HL, den Heijer M. Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study. Kidney Int 2007 72 : 632 7.
30. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int 2002 62 : 956 62.
31. Halimi JM, Giraudeau B, Vol S, Caces E, Nivet H, Lebranchu Y, et al. Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. Kidney Int 2000 58 : 1285 92.
32. Bankir L, Bouby N. Vasopressin and urinary concentration: additional risk factors in the progression of chronic renal failure. Am J Kidney Dis 1991 17 : 20 6.
33. Neuringer JR, Brenner BM. Hemodynamic theory of progressive renal disease: a 10-year update in brief review. Am J Kidney Dis 1993 22 : 98 104.
34. Metcalf P, Baker J, Scott A, Wild C, Scragg R, Dryson E. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem 1992 38 : 1802 8.
35. Hoy W, Vanbuynder P, Mathews JD, Pugsley DJ, Wang Z. Renal disease and the environment: lessons from Aboriginal Australia. Nephrology 2001 6 : 19 24.
36. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 1995 26 : 610 5.
37. Adelman RD. Obesity and renal disease. Curr Opin Nephrol Hypertens 2002 11 : 331 5.
38. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001 59 : 1498 509.
39. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005 330 : 565 72.
40. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991 266 : 237 41.